2024-516805-22-00
EU Clinical Trials Information System
- Trial ID
- T-ctis-2024-516805-22-00
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2024-516805-22-00
- Asset
- CYB003
- Sponsor, as registered
- Cybin IRL Limited
- Phase
- Therapeutic confirmatory (Phase III)
- Indication
- Major Depressive Disorder
- Status
- Authorised
- Start date
- 30/06/2026
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Czechia, Germany, Greece, Ireland, Poland
- Sites
- 18
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-08-31
Notes on the record
countries is memberStatesConcerned, i.e. every member state the trial is filed in; site_count sums trialSites across authorised Part II sections. primary_completion_date is EMPTY because CTIS does not publish a primary completion date; it is not unknown, it is not a field the registry has. Per-state authorisation is NOT recorded: mscPublicStatusCode takes values [2, 4] on this record and the registry publishes no key for them, so decoding it would be a guess.
Company
Through CYB003: Cybin
Cited in
No published issue cites this registry number.